What are PARP Inhibitors for Breast Cancer? | Lynparza (olaparib) Explained
4:09
What are PARP Inhibitors for Breast Cancer? | Lynparza (olaparib) Explained
2.2K views10 months ago
YouTubeYerbba – Breast Cancer
#olaparib | Uses, Dosage, Side Effects & Mechanism | Lynparza
8:39
#olaparib | Uses, Dosage, Side Effects & Mechanism | Lynparza
3.6K viewsOct 26, 2023
YouTubeHe-InFo
Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows | Fortune
Breast cancer drug Lynparza reduces risk of death by 28% in patients diagnosed early, clinical trial shows | Fortune
Dec 20, 2024
fortune.com
The listing of Lynparza® (olaparib) on the Pharmaceutical Benefits Scheme will save men and families $78,000 per year in scripts for the life-extending medication. Known as a PARP Inhibitor, the precision medicine is available now for eligible men with metastatic castration resistant prostate cancer linked to BRCA 1 or 2 mutations. Around 2000 men every year will now be able to take Lynparza® when their hormone therapy stops working, reducing risks of death and shrinking the tumours of around 1
1:59
The listing of Lynparza® (olaparib) on the Pharmaceutical Benefits Scheme will save men and families $78,000 per year in scripts for the life-extending medication. Known as a PARP Inhibitor, the precision medicine is available now for eligible men with metastatic castration resistant prostate cancer linked to BRCA 1 or 2 mutations. Around 2000 men every year will now be able to take Lynparza® when their hormone therapy stops working, reducing risks of death and shrinking the tumours of around 1
1.7K viewsApr 3, 2022
FacebookProstate Cancer Foundation of Australia
Leanne Citrone | After seeing my doctor today and getting bloodwork, I found out one of the side effects of Lynparza ( the maintenance drug I am taking ) is... | Instagram
0:51
Leanne Citrone | After seeing my doctor today and getting bloodwork, I found out one of the side effects of Lynparza ( the maintenance drug I am taking ) is... | Instagram
10.7K views2 months ago
Instagramleannecitrone
Lynparza tablets how to use: Uses, Dosage, Side Effects, Contraindications
3:03
Lynparza tablets how to use: Uses, Dosage, Side Effects, Contraindications
2K viewsJul 10, 2023
YouTubePharmacy Assistant
FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer
FDA Expands AstraZeneca (AZN) Lynparza Label in Prostate Cancer
Jun 2, 2023
nasdaq.com
Merck & Co., Inc. Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
Merck & Co., Inc. Announces KEYLYNK-008 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LYNPARZA® for Patients With Metastatic Squamous Non-Small Cell Lung Cancer to Stop for Futility
Dec 7, 2023
marketscreener.com
Lynparza Breast Cancer Treatment Experiences and Advice
1:09
Lynparza Breast Cancer Treatment Experiences and Advice
14.5K viewsAug 11, 2022
TikTokshayzofhope
FDA clears Lynparza for prostate cancer treatment
FDA clears Lynparza for prostate cancer treatment
Jun 7, 2023
foxsanantonio.com
Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk in HR-Positive Patients | PharmExec
Lynparza and Breast Cancer: Study Finds Reduced Recurrence Risk in HR-Positive Patients | PharmExec
Mar 11, 2025
pharmexec.com
Exciting News for Breast Cancer Treatment We’re thrilled to announce that Lynparza (olaparib) has been listed on the PBS for HER-2 negative early breast cancer with a confirmed BRCA mutation. Last year, BCNA advocated strongly for Lynparza’s subsidy as an important treatment option to help reduce the risk of breast cancer coming back after treatment for people who are at especially high risk of recurrence. We’re proud to join Minister for Health & Aged Care Mark Butler and Pink Hope CEO Sarah Po
1:18
Exciting News for Breast Cancer Treatment We’re thrilled to announce that Lynparza (olaparib) has been listed on the PBS for HER-2 negative early breast cancer with a confirmed BRCA mutation. Last year, BCNA advocated strongly for Lynparza’s subsidy as an important treatment option to help reduce the risk of breast cancer coming back after treatment for people who are at especially high risk of recurrence. We’re proud to join Minister for Health & Aged Care Mark Butler and Pink Hope CEO Sarah Po
1.1K viewsJul 3, 2024
FacebookBreast Cancer Network Australia
AstraZeneca's Lynparza gets OK as first drug aimed at women with inherited breast cancer
AstraZeneca's Lynparza gets OK as first drug aimed at women with inherited breast cancer
Jan 12, 2018
delawareonline.com
AstraZeneca breast cancer drug Lynparza is approved by EU regulators
AstraZeneca breast cancer drug Lynparza is approved by EU regulators
Aug 4, 2022
thisismoney.co.uk
AstraZeneca PLC and MSD Provides Update on US review of Lynparza PROpel sNDA
AstraZeneca PLC and MSD Provides Update on US review of Lynparza PROpel sNDA
Dec 14, 2022
marketscreener.com
Women living with BRCA-related ovarian cancer will have access to Lynparza medication from November 1. It will be listed on the Pharmaceutical Benefits Scheme helping sufferers save hundreds of thousands of dollars a year. www.7NEWS.com.au #7NEWS | 7NEWS Brisbane
0:29
Women living with BRCA-related ovarian cancer will have access to Lynparza medication from November 1. It will be listed on the Pharmaceutical Benefits Scheme helping sufferers save hundreds of thousands of dollars a year. www.7NEWS.com.au #7NEWS | 7NEWS Brisbane
4.5K viewsOct 21, 2020
Facebook7NEWS Brisbane
PARP Inhibitor Staves Off Recurrence in Early BRCA-Mutant Breast Cancer - Medpage Today
3:14
PARP Inhibitor Staves Off Recurrence in Early BRCA-Mutant Breast Cancer - Medpage Today
144 viewsJul 19, 2021
YouTubeMedPage Today
Dr. Carlos Doti Explains How AstraZeneca's LYNPARZA Has Changed Oncology
7:10
Dr. Carlos Doti Explains How AstraZeneca's LYNPARZA Has Changed Oncology
690 viewsJun 20, 2024
YouTubeDocWire
Astrazeneca et Merck annoncent que Lynparza® (Olaparib) en association avec l'abiratérone et la prednisone ou la prednisolone a reçu l'avis positif de la Chmp de l'UE comme traitement pour certains patients atteints d'un cancer de la prostate métastatique résistant à la castration
Astrazeneca et Merck annoncent que Lynparza® (Olaparib) en association avec l'abiratérone et la prednisone ou la prednisolone a reçu l'avis positif de la Chmp de l'UE comme traitement pour certains patients atteints d'un cancer de la prostate métastatique résistant à la castration
Nov 14, 2022
zonebourse.com
الآثار الجانبية Lynparza (olaparib) ، والتفاعلات ، واستخدامات وبصمة المخدرات - الصحة 2026
الآثار الجانبية Lynparza (olaparib) ، والتفاعلات ، واستخدامات وبصمة المخدرات - الصحة 2026
Aug 29, 2019
oldmedic.com
It's a silent killer that claims the lives of more than 1,000 Australian woman each and every year. Now a leading treatment for a type of genetic ovarian cancer is being subsidised, saving patients hundreds of thousands of dollars. www.7NEWS.com.au #Health #7NEWS | 7NEWS Sydney
1:20
It's a silent killer that claims the lives of more than 1,000 Australian woman each and every year. Now a leading treatment for a type of genetic ovarian cancer is being subsidised, saving patients hundreds of thousands of dollars. www.7NEWS.com.au #Health #7NEWS | 7NEWS Sydney
5.6K viewsOct 21, 2020
Facebook7NEWS Sydney
PARP Inhibitors Stops Cancer Cells from Repairing? Olaparib Explained!
0:22
PARP Inhibitors Stops Cancer Cells from Repairing? Olaparib Explained!
6.2K views8 months ago
YouTubeYerbba – Breast Cancer
OlympiA Study Demonstrates the Efficacy of Olaparib in the Treatment of Early Breast Cancer
4:20
OlympiA Study Demonstrates the Efficacy of Olaparib in the Treatment of Early Breast Cancer
217 viewsJan 23, 2025
YouTubeDocWire
BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI
11:49
BRCA & PARP Inhibitors: Targeted Chemotherapy | #MarkScholzMD #AlexScholz @PCRI
5.8K viewsJun 1, 2023
YouTubeProstate Cancer Research Institute
PARP Inhibitors in Advanced Prostate Cancers
5:40
PARP Inhibitors in Advanced Prostate Cancers
528 viewsJan 3, 2019
YouTubeOncLive
Quality of Life Data for PARP Inhibitor Shows Promise for Pancreatic Cancer Treatment
1:07
Quality of Life Data for PARP Inhibitor Shows Promise for Pancreatic Cancer Treatment
180 viewsOct 10, 2019
YouTubeOncLive
What Is Lynparza and How Does It Work in Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MD
3:25
What Is Lynparza and How Does It Work in Prostate Cancer? | Ask a Prostate Expert, Mark Scholz, MD
4.9K viewsApr 27, 2020
YouTubeProstate Cancer Research Institute
Things you should know about Lynparza, the New Pancreatic Cancer Drug
3:18
Things you should know about Lynparza, the New Pancreatic Cancer Drug
101 viewsAug 7, 2023
YouTubeAirr News
#リムパーザ (Lynparza) | 基本情報, 効能, 注意すべき副作用, 用法・用量 | オラパリブ
3:26
#リムパーザ (Lynparza) | 基本情報, 効能, 注意すべき副作用, 用法・用量 | オラパリブ
1.7K viewsFeb 11, 2023
YouTubeHe-InFo
Experiencias con Lynparza para la mutación BRCA 2
0:59
Experiencias con Lynparza para la mutación BRCA 2
1.8K viewsDec 17, 2024
TikTokbreastcancerawareness24
See more